| Pocahontas Memorial Hospital Medical Practice Rhc | |
|
150 Duncan Rd Buckeye WV 24924 | |
| (304) 799-6200 | |
| (304) 799-6636 |
| Full Name | Pocahontas Memorial Hospital Medical Practice Rhc |
|---|---|
| Speciality | Clinic/Center |
| Location | 150 Duncan Rd, Buckeye, West Virginia |
| Authorized Official Name and Position | Shannon Ruth Starcher (PROVIDER ENROLLMENT) |
| Authorized Official Contact | 3047997400 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Pocahontas Memorial Hospital Medical Practice Rhc 150 Duncan Rd Buckeye WV 24924 Ph: (304) 799-6200 | Pocahontas Memorial Hospital Medical Practice Rhc 150 Duncan Rd Buckeye WV 24924 Ph: (304) 799-6200 |
| NPI Number | 1346523206 |
|---|---|
| Provider Enumeration Date | 09/27/2011 |
| Last Update Date | 02/20/2020 |
| Medicare PECOS PAC ID | 9234100645 |
|---|---|
| Medicare Enrollment ID | O20120130000489 |
News Archive
Name a drink that can make you more alert for late-night studying, prevent you from fainting after giving blood, and even promote a teensy bit of weight loss. Chances are you didn't say water. But that's the right answer.
Uniqueness of SUSU scientists' development consists in the fact that this device unlike other analogous devices allows involving all the joints of lower limb.
A group led by Dr. Michael Teitell at UCLA has demonstrated that misregulation of the protein SPAK may contribute to B-cell lymphoma development. Their report can be found in the October 2009 issue of the American Journal of Pathology.
Regulus Therapeutics Inc., founded by Alnylam Pharmaceuticals, Inc., and Isis Pharmaceuticals, Inc., unveiled plans for an educational webinar about microRNA biology that will highlight several recent exciting discoveries in the field and showcase the therapeutic strategies based on microRNA.
AstraZeneca today announced four research collaborations aimed at harnessing the power of CRISPR, a pioneering genome-editing technique, across its entire discovery platform in the company's key therapeutic areas.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346523206 | NPI | - | NPPES |
| 3810023879 | Medicaid | WV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QR1300X | Clinic/center - Rural Health | 16 (West Virginia) | Primary |
News Archive
Name a drink that can make you more alert for late-night studying, prevent you from fainting after giving blood, and even promote a teensy bit of weight loss. Chances are you didn't say water. But that's the right answer.
Uniqueness of SUSU scientists' development consists in the fact that this device unlike other analogous devices allows involving all the joints of lower limb.
A group led by Dr. Michael Teitell at UCLA has demonstrated that misregulation of the protein SPAK may contribute to B-cell lymphoma development. Their report can be found in the October 2009 issue of the American Journal of Pathology.
Regulus Therapeutics Inc., founded by Alnylam Pharmaceuticals, Inc., and Isis Pharmaceuticals, Inc., unveiled plans for an educational webinar about microRNA biology that will highlight several recent exciting discoveries in the field and showcase the therapeutic strategies based on microRNA.
AstraZeneca today announced four research collaborations aimed at harnessing the power of CRISPR, a pioneering genome-editing technique, across its entire discovery platform in the company's key therapeutic areas.
› Verified 5 days ago